137 related articles for article (PubMed ID: 30977121)
1. A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost-effectiveness analysis.
D'Andrea E; Choudhry NK; Raby B; Weinhouse GL; Najafzadeh M
Int J Cancer; 2020 Feb; 146(3):781-790. PubMed ID: 30977121
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
[TBL] [Abstract][Full Text] [Related]
3. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
[TBL] [Abstract][Full Text] [Related]
4. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
Harewood GC; Wiersema MJ; Edell ES; Liebow M
Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
Kowada A
BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
[TBL] [Abstract][Full Text] [Related]
7. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
[TBL] [Abstract][Full Text] [Related]
8. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
Li Y; Arellano AR; Bare LA; Bender RA; Strom CM; Devlin JJ
Value Health; 2017 Apr; 20(4):547-555. PubMed ID: 28407996
[TBL] [Abstract][Full Text] [Related]
9. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
[TBL] [Abstract][Full Text] [Related]
10. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of CT screening in the National Lung Screening Trial.
Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
[TBL] [Abstract][Full Text] [Related]
13. Sixty-four-slice computed tomography of the coronary arteries: cost-effectiveness analysis of patients presenting to the emergency department with low-risk chest pain.
Khare RK; Courtney DM; Powell ES; Venkatesh AK; Lee TA
Acad Emerg Med; 2008 Jul; 15(7):623-32. PubMed ID: 19086322
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
[TBL] [Abstract][Full Text] [Related]
15. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
16. Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy.
Veronesi G; Navone N; Novellis P; Dieci E; Toschi L; Velutti L; Solinas M; Vanni E; Alloisio M; Ghislandi S
Lung Cancer; 2020 May; 143():73-79. PubMed ID: 32234647
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.
Hofer F; Kauczor HU; Stargardt T
Lung Cancer; 2018 Oct; 124():189-198. PubMed ID: 30268459
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.
Pavel AB; Campbell JD; Liu G; Elashoff D; Dubinett S; Smith K; Whitney D; Lenburg ME; Spira A;
Cancer Prev Res (Phila); 2017 Nov; 10(11):651-659. PubMed ID: 28877936
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
Puggina A; Broumas A; Ricciardi W; Boccia S
Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]